Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications

Journal of Medicinal Chemistry
Prasad DandeBalkrishen Bhat

Abstract

A systematic structure-activity relationship study of 4'-thioribose containing small interfering RNAs (siRNAs) has led to the identification of highly potent and stable antisense constructs. To enable this optimization effort for both in vitro and in vivo applications, we have significantly improved the yields of 4'-thioribonucleosides by using a chirally pure (R)-sulfoxide precursor. siRNA duplexes containing strategically placed regions of 4'-thio-RNA were synthesized and evaluated for RNA interference activity and plasma stability. Stretches of 4'-thio-RNA were well tolerated in both the antisense and sense strands. However, optimization of both the number and placement of 4'-thioribonucleosides was necessary for maximal potency. These optimized siRNAs were generally equipotent or superior to native siRNAs and exhibited increased thermal and plasma stability. Furthermore, significant improvements in siRNA activity and plasma stability were achieved by judicious combination of 4'-thioribose with 2'-O-methyl and 2'-O-methoxyethyl modifications. These optimized 4'-thio-siRNAs may be valuable for developing stable siRNAs for therapeutic applications.

References

Jul 24, 1998·Trends in Genetics : TIG·M K Montgomery, A Fire
Dec 26, 2002·The Journal of Biological Chemistry·Timothy A VickersBrenda F Baker
Jan 16, 2003·Nucleic Acids Research·Mohammed AmarzguiouiHans Prydz
Feb 13, 2003·Nature Medicine·Erwei SongJudy Lieberman
Mar 26, 2003·Journal of Molecular Biology·Dag R SørensenMouldy Sioud
Jun 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lars ZenderStefan Kubicka
Sep 27, 2003·Nucleic Acids Research. Supplement·Shuichi HoshikaAkira Matsuda
Oct 22, 2003·Cell·Dianne S SchwarzPhillip D Zamore
Feb 26, 2004·Bioorganic & Medicinal Chemistry Letters·Dwaine A BraaschDavid R Corey
Nov 13, 2004·Nature·Jürgen SoutschekHans-Peter Vornlocher

❮ Previous
Next ❯

Citations

Apr 26, 2007·Applied Microbiology and Biotechnology·Achim Aigner
Dec 14, 2011·Gene Therapy·Y Zhang, R M Friedlander
Apr 5, 2007·Nature Protocols·Mohammed AmarzguiouiJohn J Rossi
Jul 7, 2012·Organic & Biomolecular Chemistry·José M Ibarra-SozaPeter A Beal
Jul 21, 2006·Nucleic Acids Research·Naonori InoueAkira Matsuda
Dec 25, 2010·Nucleic Acids Research·Pradeep S PallanMartin Egli
Dec 7, 2007·The Journal of Clinical Investigation·David R Corey
Mar 28, 2009·International Journal of Molecular Sciences·Nicoletta PotenzaAnna Messere
Nov 17, 2006·Nature Chemical Biology·David BumcrotDinah W Y Sah
Sep 29, 2011·Advanced Drug Delivery Reviews·Yuwei Wang, David W Grainger
Mar 2, 2016·Journal of Biomaterials Science. Polymer Edition·Nitin DwivediPrashant Kesharwani
Dec 10, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Aleksandra M UrbanskaSatya Prakash
Sep 17, 2011·Chemistry & Biodiversity·Thazha P Prakash
Sep 18, 2015·Journal of the American Chemical Society·Xueguang LuKe Zhang
Aug 26, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hanuma Kumar KarnatiRavi Kumar Gutti
Jan 4, 2015·Drug Discovery Today·Prashant Kesharwani, Arun K Iyer
Sep 4, 2012·Cell·Walt F LimaStanley T Crooke
Aug 28, 2012·Chemistry & Biology·Glen F Deleavey, Masad J Damha
Jul 20, 2016·Journal of Medicinal Chemistry·W Brad Wan, Punit P Seth
May 9, 2009·Advanced Drug Delivery Reviews·Yu-Kyoung Oh, Tae Gwan Park
Jun 29, 2010·Angewandte Chemie·Laura H S SmithDavid J Procter
Jun 19, 2012·Nucleic Acid Therapeutics·Nicholas M Snead, John J Rossi
Dec 19, 2018·Chemical Biology & Drug Design·Takanori KuboToshio Seyama
Oct 10, 2007·Chembiochem : a European Journal of Chemical Biology·Shuichi HoshikaAkira Matsuda
Jul 16, 2008·Chemistry : a European Journal·Alvaro SomozaEric T Kool
Apr 17, 2010·Chemistry & Biodiversity·Jia Sheng, Zhen Huang
Aug 19, 2010·Chemical Society Reviews·James W GaynorRichard Cosstick
Feb 6, 2020·Current Pharmaceutical Design·Imran AliLuciana Scotti
Dec 17, 2009·Current Protocols in Nucleic Acid Chemistry·Glen F DeleaveyMasad J Damha
May 21, 2019·Frontiers in Pharmacology·Ivan V ChernikovElena L Chernolovskaya
Dec 17, 2014·Current Protocols in Nucleic Acid Chemistry·Noriaki Minakawa, Akira Matsuda
May 26, 2018·Critical Reviews in Biochemistry and Molecular Biology·Hong-Leong CheahThean-Hock Tang
Sep 21, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Aysha S AnsariHasan Uludağ
Feb 26, 2011·Angewandte Chemie·Muthiah ManoharanMartin Egli
Nov 12, 2009·Journal of the American Chemical Society·Daniel ChapdelaineYvan Guindon
Jun 12, 2008·Journal of the American Chemical Society·Jonathan K WattsMasad J Damha
May 11, 2021·Drug Delivery and Translational Research·Indra RautelaManish Dev Sharma
May 28, 2021·European Journal of Pharmacology·Walhan AlshaerAbdalla Awidi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.